HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK726701A

an EP4 receptor partial agonist

Also Known As:

(4-(4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo(f)isoindol-2-yl)-2-fluorophenyl)acetic acid

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Isoindoles: 18
      - GSK726701A: 1

Experts

1.	Allan, Amanda C: 1 article (01/2018)
2.	Bailey, Kristin: 1 article (01/2018)
3.	Billinton, Andy: 1 article (01/2018)
4.	Chessell, Iain P: 1 article (01/2018)
5.	Clayton, Nicholas M: 1 article (01/2018)
6.	Giblin, Gerard M P: 1 article (01/2018)
7.	Healy, Mark P: 1 article (01/2018)
8.	Kay, Melanie A: 1 article (01/2018)
9.	Khaznadar, Tarik: 1 article (01/2018)
10.	Michel, Anton D: 1 article (01/2018)

Related Diseases

1.

01/01/2018 - "This paper describes these novel ligands and their activity within a number of pre-clinical models of pain, ultimately leading to the identification of the EP4 partial agonist GSK726701A."
01/01/2018 - "Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain."

Related Drugs and Biologics

1.	Acetic Acid (Vinegar)
2.	Ligands